Carboxymethytl pachymaram up-regulates dendritic cell function in hepatitis B virus transgenic mice

Abstract

Carboxymethytl pachymaram (CMP) was administered to HBV transgenic mice through abdominal injection. Lymphocytes were extracted from the spleens. MTT method was used to detect cytotoxicity of CMP. Dendritic cells (DCs) were separated from lymphocytes and incubated with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). Phenotypes of DC’s were assayed by flow cytometry (FCM). IL-12 released by DCs and IL-10 and IFN-? produced by T cells in mixed lymphocyte reaction (MLR) were measured using ELISA. Results showed that CMP within the concentration of 0–500 ?g/mL did not produce cytotoxicity to lymphocytes and could even increase DC phenotypes, and IL-12 level in HBV transgenic mice. It could also increase the secretion of IFN-?, and inhibit the secretion of IL-10 in MLR. Thus it can up-regulate DC function.

References

1. Barratt-Boyes S M, Zimmer M I, Harshyne L A, Meyer E M, Watkins S C, Capuano S 3rd, Murphey-Corb M, Falo L D Jr, Donnenberg A D (2000). Maturation and trafficking of monocyte-derived dendriticcells in monkeys: implications for dendritic cell-based vaccines. J Immunol, 164: 2487–2495
2. Beckebaum S, Cicinnati V R, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch C E, Gerken G (2003). HepatitisB virus-induced defect of monocyte-derived dendritic cells leads toimpaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology, 109: 487–495. doi:10.1046/j.1365-2567.2003.01699.x
3. Chen C X (2002). Effect of carboxymethyl pachymaram (CMP) on immunologicalfunction in mice. Edible Fungi, 4: 39–41 (in Chinese)
4. Dakic A, Shao Q X, D'Amico A, O'Keeffe M, Chen W F, Shortman K, Wu L (2004). Development of the dendritic cell system during mouse ontogeny. J Immunol, 172: 1018–1027
5. Duan H P, Hou A J, Lu F E, Huang J L (2005). Experimental study on the inhibitory effect of carboxymethytl pachymaramon hepatitis B virus expression from transfected cells. Chinese Journal of Experimental and Clinical Virology, 19(3): 290–292 (in Chinese)
6. Ebner S, Ratzinger G, Krosbacher B, Schmuth M, Weiss A, Reider D, Kroczek R A, Herold M, Heufler C, Fritsch P, Romani N (2001). Productionof IL-12 by human monocyte-derived dendritic cells is optimal whenthe stimulus is given at the onset of maturation, and is further enhancedby IL-4. J Immunol, 166: 633–641
7. Goncalves L, Albarran B, Salmen S, Borges L, Fields H, Montes H, Soyano A, Diaz Y, Berrueta L (2004). The Nonresponse to hepatitis B vaccination is associatedwith impaired lymphocyte activation. Virology, 326: 20–28. doi:10.1016/j.virol.2004.04.042
8. Kunitani H, Shimizu Y, Murata H, Higuchi K, Watanabe A (2002). Phenotypicanalysis of circulating and intrahepatic dendritic cell subsets inpatients with chronic liver diseases. JHepatol, 36: 734–741. doi:10.1016/S0168-8278(02)00062-4
9. Lunga T L, Saurwein-Teissla M, Parsonb W, Schönitzer D, Grubeck-Loebenstein B (2000). Unimpaired dendritic cells can be derived from monocytes in old ageand can mobilize residual function in senescent T cells. Vaccine, 18: 1606–1612. doi:10.1016/S0264-410X(99)00494-6
10. MacDonald A S, Straw A D, Dalton N M, Pearce E J (2002). Cutting edge: Th2 response induction by dendritic cells: a role forCD40. J Immunol, 168: 537–540
11. Pollara G, Katz D R, Chain B M (2005). LIGHTing up Dendritic Cell Activation:Immune Regulation and Viral Exploitation. J Cell Physiol, 205(2): 161–162. doi:10.1002/jcp.20473
12. Timares L, Safer K M, Qu B, Takashima A, Johnston S A (2003). Drug-inducible,dendritic cell-based genetic immunization. J Immunol, 170: 5483–5490
13. Wakkach A, Fournier N, Brun V, Breittmayer J, Cottrez F, Groux H (2003). Characterization of dendritic cellsthat induce tolerance and T regulatory cell differentiation in vivo. Immunity, 18: 605–617. doi:10.1016/S1074-7613(03)00113-4
14. Wang H M, Xia M, Xia D Z, Sun W, Pan H M, Xiang W L (2006). Anti-tumor effect of LPS and its mechanism. Zhejiang Journal of Integrated Traditional Chineseand Western Medicine, 16(5): 291–292 (in Chinese)
15. Yang J C, Sheng W H, Li L (1998). IL-2, TNF-α, IL-6, IFNγ/αproduction induced by carboxymethytl pachymaram (CMP) and pilot test. Immunological Journal, 14(3): 194–197 (in Chinese)